$3.4MSeed, 7 May 2026
Funds will complete product development and run a first-in-human study.
- Amount
- $3.4M
- Stage
- Seed
- Announced
- 7 May 2026
- Lead
- bmp Ventures
- Other investors
- IBG Fonds, High-Tech Gründerfonds
- Use of funds
- Funds will complete product development and run a first-in-human study.
- Checked
- Announced by the company
- Sources
- Sedivention raises €2.9M seed for outpatient obesity therapy htgf.de
Sedivention raises €2.9M seed for outpatient obesity therapy pulse2.com